Literature DB >> 25214620

Antibiotic effectiveness: balancing conservation against innovation.

Ramanan Laxminarayan1.   

Abstract

Antibiotic effectiveness is a natural societal resource that is diminished by antibiotic use. As with other such assets, keeping it available requires both conservation and innovation. Conservation encompasses making the best use of current antibiotic effectiveness by reducing demand through vaccination, infection control, diagnostics, public education, incentives for clinicians to prescribe fewer antibiotics, and restrictions on access to newer, last-resort antibiotics. Innovation includes improving the efficacy of current drugs and replenishing effectiveness by developing new drugs. In this paper, I assess the relative benefits and costs of these two approaches to maintaining our ability to treat infections.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25214620     DOI: 10.1126/science.1254163

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  48 in total

1.  [Antimicrobial resistance].

Authors:  B Salzberger; T Welte
Journal:  Internist (Berl)       Date:  2015-11       Impact factor: 0.743

Review 2.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

Review 3.  Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.

Authors:  Jens Rolff; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

Review 4.  Resistance-resistant antibiotics.

Authors:  Eric Oldfield; Xinxin Feng
Journal:  Trends Pharmacol Sci       Date:  2014-11-05       Impact factor: 14.819

5.  Remodeling vancomycin yields a victory in the battle against bacteria.

Authors:  Steven L Castle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

6.  N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.

Authors:  Zsolt Szűcs; Ilona Bereczki; Erzsébet Rőth; Márton Milánkovits; Eszter Ostorházi; Gyula Batta; Lajos Nagy; Zsuzsanna Dombrádi; Anikó Borbás; Pál Herczegh
Journal:  J Antibiot (Tokyo)       Date:  2020-05-15       Impact factor: 2.649

7.  Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria.

Authors:  Katherine A Hurley; Victoria A Heinrich; Jeremy R Hershfield; Samandra T Demons; Douglas B Weibel
Journal:  ACS Med Chem Lett       Date:  2015-03-01       Impact factor: 4.345

Review 8.  Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.

Authors:  Simone Becattini; Ying Taur; Eric G Pamer
Journal:  Trends Mol Med       Date:  2016-05-10       Impact factor: 11.951

9.  Peripheral modifications of [Ψ[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics.

Authors:  Akinori Okano; Nicholas A Isley; Dale L Boger
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

10.  A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

Authors:  José-María López-Lozano; Timothy Lawes; César Nebot; Arielle Beyaert; Xavier Bertrand; Didier Hocquet; Mamoon Aldeyab; Michael Scott; Geraldine Conlon-Bingham; David Farren; Gábor Kardos; Adina Fésűs; Jesús Rodríguez-Baño; Pilar Retamar; Nieves Gonzalo-Jiménez; Ian M Gould
Journal:  Nat Microbiol       Date:  2019-04-08       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.